IPO
LOGIN
OPEN A DEMAT ACCOUNT
IPO
Login
Open a
Demat
Account
HOME
ABOUT US
PRODUCTS
Equity
Currency
Commodity
IPO
Mutual Funds
PMS
SLBM
SERVICES
Investment Banking
Institutional Equities
Wealth Management
Depository
TRADE WITH SYSTEMATIX
Partner With Us
Trading Simplified
Payment Gateway
Link UPI
KYC Updation
ReKYC
(Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
Bank Details
Account Opening Process
Incapacitated investor
RESEARCH
MARKETS
Overview
Equity
Derivatives
IPO
Mutual Funds
Commodity
Currency
Company Info
INVESTORS
Investor Login
Investor Relations
Investor Grievances
ODR
Scores
Downloads
Investor Charter
Information to Physical Shareholders
Procedure for Filing a Complaint
Investor Education
CONTACT US
Our Reach
Careers
OPEN A DEMAT ACCOUNT
HOME
ABOUT US
PRODUCTS
EQUITY
CURRENCY
COMMODITY
IPO
MUTUAL FUND
PMS
SLBM
SERVICES
INVESTMENT BANKING
INSTITUTIONAL EQUITIES
WEALTH MANAGEMENT
DEPOSITORY
TRADE WITH SYSTEMATIX
PARTNER WITH US
TRADING SIMPLIFIED
PAYMENT GATEWAY
LINK UPI
KYC UPDATION
ReKYC (Document Reactivation/Modification in Account/Nominee Registration/Account Closure)
BANK DETAILS
ACCOUNT OPENING PROCESS
Incapacitated investor
RESEARCH
MARKETS
OVERVIEW
EQUITY
DERIVATIVES
IPO
MUTUAL FUND
COMMODITY
CURRENCY
COMPANY INFO
INVESTORS
INVESTOR LOGIN
INVESTOR RELATIONS
INVESTOR GRIEVANCES
ODR
SCORES
DOWNLOADS
INVESTOR CHARTER
INFORMATION TO PHYSICAL SHAREHOLDERS
PROCEDURE FOR FILING A COMPLAINT
Investor Education
CONTACT US
OUR REACH
CAREERS
Equity
Derivatives
Currency
Mutual Fund
IPO Analysis
Daily Market Tracker
Gainers & Losers
Value & Volume Toppers
52 Week Highs & Lows
New Highs & Lows
Buyers & Sellers
Out/Under Performers
Bulk Deals
Block Deals
Unusual Volume
Rising Volume
Exchange Holidays
5 Days Up & Down
Index Movers
Index Overview
Top Sectors
News & Analysis
Pre Session Commentary
Mid Session Commentary
End Session Commentary
Quick Review
Market Beat
Stock Alert
Hot Pursuit
Foreign Markets
Economy News
Corporate News
Corporate Results
Other Markets
Futures Markets
Corporate Information
Company Snapshot
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Previous Quarter Comp
Director's Report
Score Board
Mutual Fund Holdings
Announcements
Peer Comparison
Technical Chart
Corporate Actions
Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Name Change
Split Of Face Value
Event Calendar
Other Markets
ADR Prices
FII Investments
MF Investments
Forex Details
World Indices
GDR Prices
Equity
Derivative
Currency
Commodity
Mutual Fund
IPO
Price Analysis
Volume Analysis
News Analysis
Market Option
Other Option
Company Information
Gainers & Losers
52 Week High Low
News Highs and Low
Advances & Declines
Home
Market Info
Corporate Information
Company Snapshot
Company Snapshot
BSE
Aarti Pharmalabs Ltd
BSE Code
543748
ISIN Demat
INE0LRU01027
Book Value (₹)
203.41
NSE Symbol
AARTIPHARM
Div & Yield %
0.58
Market Cap (
₹
Cr.)
7,832.38
P/E *
29.96
EPS *
28.84
Face Value (₹)
5
* Profit to Earning Ratio
* Earning Per Share
Stock Price Details
Last Price (₹)
844.95
Change
21.05 (2.50%)
Best Buy (₹)
0.00
Best Sell (₹)
0.00
Today's Range
836.75 - 869.55
52-Week Range
550.25 - 971.50
Beta (1 Year)
0.97
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Corporate Announcements
Aarti Pharmalabs to declare Quarterly Results
Aarti Pharmalabs Ltd - Aarti Pharmalabs Limited - Reply to Clarification- Financial results
Aarti Pharmalabs Ltd - Aarti Pharmalabs Limited - Reply to Clarification- Financial results
Aarti Pharmalabs Ltd - Ex-Parte Ad-Interim Injunction Order Regarding Pharmaceutical Drug Product Containing Ruxolitinib And/Or Ruxolitinib ...
Aarti Pharmalabs Ltd - Aarti Pharmalabs Limited - General Updates :
Aarti Pharmalabs Ltd - Aarti Pharmalabs Limited - Trading Window
Aarti Pharmalabs Ltd - Aarti Pharmalabs Limited - Trading Window
Aarti Pharmalabs Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Aarti Pharmalabs Ltd - Aarti Pharmalabs Limited - Investor Presentation
Aarti Pharmalabs Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM
Corporate Details
Incorporation Year :
2019
Chairman :
C V Gogri
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office :
Aarti Pharmalabs Ltd
Plot No 22/C/1 & 22/C/2,
1st Phase GIDC Vapi,
Valsad,
Gujarat - 396195,
Phone : 91-22-6797 6666,
Fax : 91-22-2565 3234
E-Mail :
co.apl@aartipharmalabs.com ; investorrelations@aar
URL :
https://www.aartipharmalabs.com
Investor Returns
Period
Date
Price
Returns (%)
1Week
31-Oct-2025
850.90
1.55
1Month
07-Oct-2025
830.30
4.06
3Month
07-Aug-2025
838.95
2.99
6Month
07-May-2025
736.95
17.25
1Year
07-Nov-2024
687.85
25.62
Mutual Funds Holding
Scheme Name
% Holding
Market Value
HDFC Multi Cap Fund
0.19
36.53
Motilal Oswal Nifty Microcap..
0.55
14.36
HDFC Large and Mid Cap Fund
0.02
5.75
Unifi Flexi Cap Fund
2.40
3.52
Motilal Oswal BSE Healthcare..
0.32
0.10
Peerset : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company
Last Price (₹)
Change (%)
52Week High (₹)
52Week Low (₹)
Market Cap (₹ Cr.)
Sun Pharmaceutical Industries Ltd
1,692.75
0.42
1,910.00
1,547.25
406,147.43
Cipla Ltd
1,504.45
0.29
1,672.20
1,310.05
121,525.14
Dr Reddys Laboratories Ltd
1,205.30
0.02
1,404.60
1,025.90
100,596.00
Zydus Lifesciences Ltd
943.80
0.81
1,059.00
797.05
94,968.36
Mankind Pharma Ltd
2,263.30
-1.99
3,050.00
2,115.50
93,419.63
Index Details
BSE HC, BSE SmallCap